BSC
ALT icon

BOLTON SECURITIES CORPORATION’s Altimmune ALT Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$995 Buy
+348
New +$1.07K ﹤0.01% 2167

Other funds holding ALT

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's ALT Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Altimmune (ALT) in Q3 2026: 348 shares worth $995. The stake represents ﹤0.01% of the portfolio and ranks #2167 among its holdings.

92 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 348 shares of Altimmune worth $995 as of Q3 2026.
  • Altimmune was a new BOLTON SECURITIES CORPORATION position in Q3 2026.
  • Altimmune made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #2167 holding.
  • 92 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.